Cater Barnard PLC
15 October 2001
Cater Barnard plc ('Cater Barnard' or 'the Company')
Disposal of Think Direct Marketing Inc.
The Board of Cater Barnard announces today that it has agreed to conditionally
sell its 17.5% investment and its option to acquire the remaining 82.5% in
Think Direct Marketing Inc. ('TDMI'), a company based in Connecticut and
Colorado USA, to IMX Pharmaceuticals Inc. ('IMX'), a NASDAQ quoted company.
The consideration payable by IMX is US$16,800,000 to be satisfied by the issue
to Cater Barnard of 933,333 ordinary shares in IMX at $4 per share, the issue
of $1,866,668 in Loan Notes and $11,200,000 in preference shares in IMX. The
investment in TDMI was acquired by Cater Barnard by way of several equity
investments between February 2000 and May 2000 and the book value of the
investment and option is £8.925m.
The preference shares which have a par value of $80, are convertible into
equity in IMX Pharmaceuticals at the rate of 20 ordinary shares per preference
share. The preference shares are redeemable after 31 January 2003. Both the
preference shares and loan notes will pay interest annually at 5%. The loan
notes are repayable on 31 December 2006.
The ordinary shares in IMX which form part of the consideration will be sold
by Cater Barnard in due course to raise additional working capital for the
Company.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.